News US imposes limits on COVID-19 boosters and new jabs The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.
News FDA finally okays Novavax's COVID-19 jab, with restrictions The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.
News EC's von der Leyen loses bid to stop disclosure of Pfizer te... Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer's CEO on COVID-19 vaccine procurement.
News RFK Jr launches database project to explore autism causes A project to use federal databases to identify the "root causes of autism" has been launched by HHS, but there are concerns about its credibility.
News Vinay Prasad will replace Marks as CBER director COVID-19 vaccine mandate critic Vinay Prasad has been named as director of the FDA's Center for Biologics Evaluation and Research (CBER).
News US is planning $500m project on 'universal vaccines;' WSJ The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.